195 related articles for article (PubMed ID: 29706449)
1. Predictors of 'all-cause discontinuation' of initial oral antipsychotic medication in first episode psychosis.
Mustafa S; Joober R; Lepage M; Iyer S; Shah J; Malla A
Schizophr Res; 2018 Nov; 201():287-293. PubMed ID: 29706449
[TBL] [Abstract][Full Text] [Related]
2. To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial.
Begemann MJH; Thompson IA; Veling W; Gangadin SS; Geraets CNW; van 't Hag E; Müller-Kuperus SJ; Oomen PP; Voppel AE; van der Gaag M; Kikkert MJ; Van Os J; Smit HFE; Knegtering RH; Wiersma S; Stouten LH; Gijsman HJ; Wunderink L; Staring ABP; Veerman SRT; Mahabir AGS; Kurkamp J; Pijnenborg GHM; Veen ND; Marcelis M; Grootens KP; Faber G; van Beveren NJ; Been A; van den Brink T; Bak M; van Amelsvoort TAMJ; Ruissen A; Blanke C; Groen K; de Haan L; Sommer IEC
Trials; 2020 Feb; 21(1):147. PubMed ID: 32033579
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
[TBL] [Abstract][Full Text] [Related]
5. Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis.
Mustafa S; Joober R; Iyer S; Shah J; Lepage M; Malla A
J Clin Psychiatry; 2019 Aug; 80(5):. PubMed ID: 31509359
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
7. Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability.
Noguera A; Ballesta P; Baeza I; Arango C; de la Serna E; González-Pinto A; Parellada M; Graell M; Moreno C; Otero S; Castro-Fornieles J
J Clin Psychopharmacol; 2013 Aug; 33(4):463-71. PubMed ID: 23771198
[TBL] [Abstract][Full Text] [Related]
8. Predictors of hospitalisation and recovery following full antipsychotic discontinuation in first episode psychosis. A naturalistic retrospective cohort study.
Wilson M; Harris M; Pereira M; Buckle J; Forshall E; Murphy T; Thompson A; Kavanagh G; Whale R
Schizophr Res; 2023 Nov; 261():269-274. PubMed ID: 37862826
[TBL] [Abstract][Full Text] [Related]
9. Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review.
Bowtell M; Ratheesh A; McGorry P; Killackey E; O'Donoghue B
Schizophr Res; 2018 Jul; 197():9-18. PubMed ID: 29146020
[TBL] [Abstract][Full Text] [Related]
10. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
11. Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.
Alvarez-Jimenez M; O'Donoghue B; Thompson A; Gleeson JF; Bendall S; Gonzalez-Blanch C; Killackey E; Wunderink L; McGorry PD
CNS Drugs; 2016 May; 30(5):357-68. PubMed ID: 27106296
[TBL] [Abstract][Full Text] [Related]
12. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-term follow-up of a 2-year randomized clinical trial.
Wunderink L; Nieboer RM; Wiersma D; Sytema S; Nienhuis FJ
JAMA Psychiatry; 2013 Sep; 70(9):913-20. PubMed ID: 23824214
[TBL] [Abstract][Full Text] [Related]
13. Course of weight gain and metabolic abnormalities in first treated episode of psychosis: the first year is a critical period for development of cardiovascular risk factors.
Pérez-Iglesias R; Martínez-García O; Pardo-Garcia G; Amado JA; Garcia-Unzueta MT; Tabares-Seisdedos R; Crespo-Facorro B
Int J Neuropsychopharmacol; 2014 Jan; 17(1):41-51. PubMed ID: 24103107
[TBL] [Abstract][Full Text] [Related]
14. The relapse rate and predictors of relapse in patients with first-episode psychosis following discontinuation of antipsychotic medication.
Di Capite S; Upthegrove R; Mallikarjun P
Early Interv Psychiatry; 2018 Oct; 12(5):893-899. PubMed ID: 27734591
[TBL] [Abstract][Full Text] [Related]
15. Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis.
Bowtell M; Eaton S; Thien K; Bardell-Williams M; Downey L; Ratheesh A; Killackey E; McGorry P; O'Donoghue B
Schizophr Res; 2018 May; 195():231-236. PubMed ID: 29066258
[TBL] [Abstract][Full Text] [Related]
16. Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort.
Vázquez-Bourgon J; Mayoral-van Son J; Gómez-Revuelta M; Juncal-Ruiz M; Ortiz-García de la Foz V; Tordesillas-Gutiérrez D; Ayesa-Arriola R; Bioque M; Crespo-Facorro B
Int J Neuropsychopharmacol; 2021 Jan; 24(1):1-7. PubMed ID: 32840607
[TBL] [Abstract][Full Text] [Related]
17. Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis.
Thompson A; Singh S; Birchwood M
Early Interv Psychiatry; 2016 Aug; 10(4):355-61. PubMed ID: 25962446
[TBL] [Abstract][Full Text] [Related]
18. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
19. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
20. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
